IDH1 and glioma: The analysis of LN18 IDH1 mutant (R132H) and wild-type glioma cells demonstrated comprehensive coverage of primary metabolic pathways and revealed alterations in PPP, TCA cycle, glyoxylate and aldarate metabolism.